COVAX, Global Access to COVID-19 Vaccines, a global initiative aimed at equitable access to COVID-19 vaccines, has joined voices calling on European Union member states to recognize all WHO-approved vaccines as valid evidence of immunity. For travel and not only those approved by the European Medicines Agency (EMA).
In a press release published by the World Health Organization, one of the founders of COVAX, the latter called on all regional, national and local government authorities to recognize all vaccines that have been approved as effective by WHO and/or 11 Stringent Regulatory Authorities (SRAs) when making decisions About who can travel or attend events.
“As travel and other possibilities begin to open up in some parts of the world, COVAX urges all regional, national and local government authorities to identify all people who have received COVID-19 vaccines deemed safe and effective by the World Health Organization and/or 11 stringent regulatory authorities (SRAs). ) have approved COVID-19 vaccines, when making decisions about who can travel or attend events,” the press release notes.
It also asserts that measures that allow only people vaccinated with select vaccines to travel, and not all WHO-approved vaccines, are effectively creating a two-tiered system, widening the world’s division over the global COVID-19 vaccine.
According to COVAX, this division will negatively affect the growth of economies around the world at a time when the world is trying hard to resume trade, commerce and travel.
The press release notes that “such moves are already undermining confidence in life-saving vaccines that have already been shown to be safe and effective, affecting vaccine uptake and potentially putting billions of people at risk.”
It also commends countries that have accepted travel vaccines approved by the World Health Organization (EUL) and/or the eleven stringent regulatory authorities (SRAs) approved for COVID-19 vaccines as being valid for travel vaccines.
At the start of the week, TheSchengen.com reported that travelers who have been vaccinated with the AstraZeneca vaccine produced by Serum Institute India (SII) known as Covishield are not allowed to enter all EU member states under the EU Digital Vaccination Passport.
So far, Estonia, Spain, Iceland, Slovenia and Greece have confirmed that they accept Covishield as a travel-friendly immune vaccine.
However, the differences in the vaccines accepted by the member states have created confusion among travelers. This new tool developed by VisaGuide.World allows travelers to check if their travel destination country has approved the vaccine that a traveler has been immunized against against COVID-19.
Over a year ago, in April 2020, TheSchengen.com reported that proof of vaccination would definitely become mandatory for those wishing to travel throughout the Schengen area once the vaccine was approved and made available.